Litšobotsi tse qobelloang ka ho lemalla boitšoaro: boemo ba papali ea papali ea chelete (2012)

Mathata. 2012 Oct; 107 (10): 1726-34. Doi: 10.1111 / j.1360-0443.2011.03546.x. Epub 2011 Oct 10.

el-Guebaly N1, Mudry T, Zohar J, Tavares H, Potenza MN.

inahaneloang

LITLHAHISO:

Ho hlalosa, maemong a DSM-V, ho shebella ho lemalla le ho qobella ho hlaha joang ha ho nahanoa ka tšebeliso ea thuto ea methapo ea methapo (pathological) (PG).

LITLHAHISO:

Tlhahlobo e hlophisitsoeng ea lingoliloeng bakeng sa tlhahlobo e ntlafalitsoeng ea PG e le tšibollo.

LIKOTSO:

Liphumano li kenyelletsa: (ii) menehelo e tloaelehileng ea methapo ea pelo (dopamine, serotonin) ho PG le mathata a ts'ebeliso ea lithethefatsi (SUDs); (iii) ts'ehetso ea neuroimaging bakeng sa li-neurocircuitries tse arolelanoeng lipakeng tsa 'boits'oaro' le lithethefatsi le phapang lipakeng tsa boloetse bo fetelletseng ba khatello ea kelello (OCD), mathata a ho laola maikutlo (ICDs) le SUDs; (iv) liphuputso tsa liphatsa tsa lefutso tse amanang haufi-ufi le li-endophenotypic constructures tse kang ho qobelloa le ho hloka maikutlo ho feta mathata a kelello; (v) mehato ea kelello joalo ka ho qoba kotsi ho supa kamano e haufi lipakeng tsa SUDs le PG ho fapana le OCD; (vi) lintlha tsa liteko tsa sechaba le tsa kalafo ea meriana tse tšehetsang kamano e haufi lipakeng tsa SUDs le PG ho fapana le OCD. Mekhoa ea kalafo e fetotsoeng, joalo ka kalafo e pepesang, e bonahala e sebetsa ho OCD, PG kapa SUDs, e fana ka maikutlo a tse ling tsa lintho tse tloaelehileng mathateng.

CONCLUSIONS:

PG e arolelana ho tšoanang le li-SUD ho feta le OCD. Hoa tšoana le ho etsa lipatlisiso tsa khatello ea maikutlo, lithuto tsa ho qobelloa li boloka lintlha tse nang le leseli mabapi le thupelo, tlhahlobo ea bongaka le kalafo ea PG, SUDs le OCD.

Keywords: Compulsivity, Impulsivity, Addiction, Pathological Gossip, Endophenotypes

Selelekela

Phehisano e teng mabapi le ho nepahala ha ho nka ho becha ha methapo ea kutlo (pG) joalo ka taolo e sa reroang, e shebaneng le matla kapa e lematsang (1;2) ha likarolo tsa bosholu, ho qobella, le bokhoba li bonoa ho PG (3). Phehisano ena e nakong ka nako e le Buka ea ho hlahloba le ea Statistical ea Mathata a kelello

(DSM-5) ea hlaha (4;5). Liphetoho tse lebelletsoeng li kenyelletsa ho hlophisoa bocha ha PG ho tsoa mokhatlong oa Impulse Control Disorders (ICDs) ho o mong oa mathata a amanang le tlhekefetso1) le lefu la ho sithabetsoa ke kelello (OCD) ho tloha sehlopheng sa mathata a ho tšoenyeha ho isa ho a mang a likhathatso tse nang le tšebeliso ea pono (OCSDs) (6), moo li-ICD li tšoauoang ka ho reka ka bongata, ts'ebeliso ea marang-rang, kapa boitšoaro ba thobalano li ka kenyelletsoa (7). Ho tsoa ho liphetoho tsena tse reriloeng ke mohopolo o ntseng o eketseha ho ho lemalla le ho qobella ho nahanisisa ka li-ICD ka har'a nomenclature e ncha. Mona re lekola tšubuhlellano e ngata e ka tlisoang ke ho qobelloa le bokhoba mabapi le PG, mathata a ts'ebeliso ea lithethefatsi (SUDs), le OCD hammoho le mela ea phenomenological le neurobiological, 'me re tšohla moelelo oa kalafo.

Commonalities lipakeng tsa litlhaloso le litekanyetso

Karolo ea ts'ebeliso ea lisebelisoa ho DSM-IV-TR ke hore "ts'ebeliso e ntse e tsoela pele leha e le tsebo ea ho ba le bothata bo phehellang kapa bo etsahalang 'meleng kapa kelellong" (8). Poleloana ena e qoba pherekano e amanang le mefuta e sa amaneng le tlhekefetso (mohlala, joalo ka ha batho ba nka bohanyetsi ba beta-adrenergic bakeng sa khatello ea mali). Ka likarolo tse amanang le ho fokotseha ho itaola le ho lakatsa (9, ho lemalla ho kenyelletsa tšebeliso e mpe ea lithethefatsi leha ho e-na le litlamorao tse mpe (10), ho fana ka maikutlo a hore bokhoba ba lithethefatsi ha bo felle feela tšebeliso ea lithethefatsi (11;12). E ts'oanang le bokhoba ba lithethefatsi, PG e ka kenyelletsa liteko tse sa atleheng tsa ho laola, ho fokotsa, kapa ho emisa papali ea chelete; ho ikutloa o sa phomole kapa o sa tenehe ha o leka ho fokotsa kapa ho khaotsa ho becha; le ho fokotsa bokhoni ba ho hanela tšusumetso ea ho becha le ha ho na le litlamorao tse mpe kapa tse mpe tsa boits'oaro ba papali ea chelete (8).

Ho qobella ho OCD ho kenyelletsa ho etsa liketso tse sa thabiseng hangata ka mokhoa oa tloaelo ho qoba litlamorao tse lebelletsoeng, tse lebisang ho senyeng ha tšebetso (13;14;15). Maikutlo a setso a kelello a amanang le ts'ebetso ea kelello a amahanya boits'oaro bo hatellang ho bonoa, mehopolo eo ka ho felletseng e khetholloang ke lipelaelo tse sa feleng mabapi le menahano le boits'oaro ba motho, ho tsilatsila, maikutlo a ho se phethahale le ho tebisa kotsi. Litšobotsi tse joalo li khothaletsoa hore li be le metso ea tsona mothong, eo ho thoeng ke tšobotsi ea anankastic. Sebopeho sa tšobotsi e ke keng ea arajoa se tla araba tlhokahalo e pheta-phetoang ea ho pheta boits'oaro bo itseng ho hlakola bohlasoa bo sa feleng, ka hona, bo hlakisa mohopolo o thehiloeng (16). Ho tšoana hoa phenomenology e amanang le OCD, li-ICD le bokhoba ba lithethefatsi li ka kenyelletsa ho kenya letsoho liketsong tse bonahalang li qobella ho thibela kapa ho fokotsa khatello (8), matšoenyeho kapa khatello ea maikutlo pele a nka karolo liketsong tsa boitšoaro, le phomolo nakong ea ts'ebetso ea boits'oaro (9).

Karolo ea phenomenological ea ho qobelloa

a. Ho na le phetoho e susumetsang?

Mefuta e mengata ea bokhoba ba tlhekefetso e hatisa mohopolo ho tloha tlhotlheletsong ho ea ho khothalo, phetoho ho tloha ho khothaletso e ntle ea tšusumetso ho ea ho lits'ebetso tse mpe tsa morao-rao le mekhoa ea boiketsetso (9;17-21). Ho ka ba le ts'oaetso ea ho ikatisa e ka hlahang, e hlahisang likarolo tsa ts'epahalo, ka maikutlo a seng monate (mohlala, dysphoria, ho tšoenyeha, ho teneha) ha ho fihlella ts'ebeliso ea lithethefatsi kapa lithethefatsi. Boemo bona bo seng botle bo ka tlatsetsang ho qobelloang ka matlafatso e mpe (9;20;22).

b. Dichotomy ea "ego-syntonic / ego-dystonic" e fapane hakae?

Le ha ho ka ba le likarolo tse tšoanang tse qobelloang ho PG, OCD, le bokhoba ba lithethefatsi, ho boetse ho na le phapang. Ho lemalla bokhoba ba lithethefatsi le litloaelo tsa boits'oaro bo tšoanang le PG li hlalositsoe e le sebopeho sa "ego", ho bolelang hore hangata li etelletsoa pele ke maikutlo a "menyaka, ho ikholisa kapa ho phomola ka nako ea ho etsa ketso eo" (8). Ho OCD, boits'oaro bo qobelloang hangata bo phethoa ho hatella kapa ho khelosa maikutlo le ho fokotsa tsitsipano le matšoenyeho a amanang le ho tebela maikutlo (8). Liphetso tsena ka tloaelo li nkuoa e le li-ego-dystonic ka tlhaho. Kahoo, sepheo se khothalletsang boits'oaro bo bobebe ho litumelo le OCD li ka fapana. Leha ho le joalo, litloaelo tse lemalloang li ka fokola ka sebopeho sa 'mele oa motho le ho feta ha nako e ntse e feta, kaha boits'oaro kapa litlamorao tsa ntho li sa khahlise ebile li tloaetse ho feta kapa li qobella (9;20;22-24). Ka mokhoa o ts'oanang, ho bua ka lintho tse qobelloang ho OCD joalo ka ha li "sa thabise" ho ka se be joalo kamehla, joalo ka bongoaneng OCD, kapa batho ba liphallelo ba ka fumana kamora ho "hloekisa hantle" kapa khotsofalo e hlophiselitsoeng ho hlophisa ho fihlela "mosebetsi o phethoe"25).

c. Ho mamella le ho tlohela

Ho ba teng ha mamello e kanna ea tšoana e 'ngoe lipakeng tsa bokhoba ba lithethefatsi, PG, le OCD, ka sepheo sa ho eketsa botebo ba boits'oaro bo phetoang ha nako e ntse e feta (26;27). Khothatso kapa takatso ha o ntse o qoba boits'oaro e kanna ea ts'oana le litakatso nakong ea ho khaotsa lithethefatsi bokhobeng ba lithethefatsi (1). Phetoho ea ts'ebeliso ea lithethefatsi ho lemalla e boetse e nahanne le mabapi le neuroplasticity, moo ho pepesehelang lithethefatsi tsa tlhekefetso boemo bo khothalletsang "ho batla", bo amanang le ts'ebeliso e qobelloang, bo nkang karabo ea "ho rata" kapa ea hedonic (28).

Litekanyetso tsa Neurobiological tsa khatello

a. Li-Neurotransmitters

Lisebelisoa tse ngata tsa li-neurotransmitter li kenya letsoho ho lemeng ha lithethefatsi le PG, tse ngata li amehile ho OCD; le ha ho le joalo, datha e bonts'a phapang ea mofuta oa ho kenya letsoho ha lits'ebetso tsena ho PG le OCD (23).

Serotonin (5-HT) e kenya letsoho ho sitiseng boitshwaro le dopamine (DA) ho ithuteng, ho susumetsang, le boiketlo ba ho susumetsa, ho kenyeletsa le meputso (29). Liphephetso tsa meriana ea 5-HT le dopamine system (30-34) fana ka maikutlo a phapang ea mofuta oa ho kenya letsoho ha lits'ebetso tsena ho OCD ha e bapisoa le PG le SUDs. Ho latela phephetso ka serotonergic agonist joalo ka pakane ea bona-chlorophenyl piperazine (m-CPP), bakuli ba OCD ba tlaleha ho eketseha ha matšoao a OC (33). Batho ba nang le PG ba na le monyetla oa ho tlaleha karabo e kholo kapa e "phahameng" ho m-CPP, e ts'oanang le likarabo tse bonoang lithutong tse itjelletseng ka joala (31).

b. Neurocircuitry

Lintlha tsa Neuroimaging li ts'ehetsa li-neurocircuitry tse arolelanoang tsa litloaelo tsa boits'oaro le lithethefatsi tse hlahang ka mokhoa o fapaneng ho OCD (20). Frontostriatal circry e etsa hore ho be le khetho e kenelletseng litabeng tsa bokhoba ba lithethefatsi (18) le PG (35;36). Ho se sebetse hantle ha litšupa-nako tsa "striato-thalamo-cortical circry"37).

Li-circuits tsa Frontal-striatal li na le tšusumetso ho OCD, ICD ho lefu la Parkinson (PD), le boits'oaro bo batlang cocaine (38). Ka mohlala o le mong (38), sistimi e ka pele ea pele e amanang le lintlha tse khahlisang e sebetsana le tsamaiso e sebetsang ea dorsal pele. Ho li-ICD ho PD, ho se lekane pakeng tsa tsamaiso ea methapo le methapo ea methapo, karolong e amanang le PD pathology le / kapa litlhare tsa DA tse sebelisitsoeng ho phekola lefu lena, li ka ba teng (39). Bokhobeng ba lithethefatsi, ho se leka-lekane ha li-system tsa ventral le tsa motor li ka fetoha habonolo ka nako, ho tloha ho kenya letsoho ha ventral ho ea ho dorsal circry (40-42).

Litakatso tsa lithahasello tsa lithethefatsi le litloaelo tsa boits'oaro li amahantsoe le ts'ebeliso e mpe ea ts'ebetso ea moea oa ts'ebetso ea moea.43), e ts'oanang le liphumano nakong ea ts'ebetso ea moputso kapa papali ea chelete ea papali ea chelete ka hara PG le bokhoba ba tahi (44;45). Ho nka karolo ha mosebetsi oa papali ea chelete ho ka etsa hore DA e lokolloe maemong a phahameng bathong ba nang le PD le PG ho feta ho batho ba nang le PD feela (46), karabelo e ts'oanang le e hlahisitsoeng ke lithethefatsi kapa likotsi tse amanang le lithethefatsi ho batho ba lemaletseng lithethefatsi (47) kapa lithutong tsa PD tse sebelisang lithethefatsi tse nkang DA ka mokhoa o feteletseng (48). Ts'ebetso e ntseng e eketseha ea potoloho ea pele e bonoe ka mor'a ho pepesetsoa ha cue ho OCD (49), athe ts'ebetso e fokotsehile e bonoe ho PG (50), e totobatsa tlhoko ea tlhahlobo e ts'oanang ea PG, OCD, lithuto tse amanang le lithethefatsi le taolo (23).

Koob le Volkow (9) ba pheha khang ea hore ho susumetsa ho laola maemo a pele a bokhoba, 'me ho susumetsa ho kopantsoeng le ho qobelloa ho busa maemong a kamorao. Ba hlahisa methati e meraro ea potoloho ea bokhoba ba ho lematsa: 'ho itlopa joala / ho tahoa', 'ho khaola / ho ama hampe', le 'ho nahanisisa' (ho lakatsa). Ka mohlala oa bona, sebaka se kenellang sethaleng le ho kenella linthong tse tahang li kenya letsoho haholo molemong oa ho itlopa lijo tse tahang kapa tse tahang, li-amygdala tse atolositsoeng (ho kenyeletsoa libaka tsa amygdala, stria terminalis le li-nucleus) tse tlatsetsang haholo sethaleng sa ho ama / ho se sebe, le ho lebella / ho lebella / ho lebella sethala se kenyelletsa marang-rang a phatlalalitsoeng ka bongata a amanang le orbitof Pambal cortex-dorsal striatum, preortalal cortex, basolateral amygdala, le hippocampus. Insula e tlatsetsa ho lakatseng, gingus, cingrate gorsus, dorsolateral pre-preal, le inferior frontal cortices ho mafutsana a thibelo a thibelo ea taolo, le lefu la ho itlhahisa le nang le tšusumetso e mpe le mmuso ho ama maemo a ho hloka matla (9;22).

Ho nahanoa ka ho khaola ho tsubelletseng ho PG hoa utloahala kaha ho tlalehiloe ho khaola ha kelello ho PG (1;51). Ntle le moo, papali ea chelete mabapi le khatello ea maikutlo (24) le ho sebetsana le khatello ea maikutlo ho boletsoe e le litlatsetso tsa ho kenya letsoho ho PG (52). Ka mokhoa o ts'oanang, ho ts'oara lithethefatsi bokhobeng ba lithethefatsi le boits'oaro bo qobelloang ho OCD ho ka etsoa ho fokotsa khatello ea maikutlo (8).

Lubman et al. (53) tlhokomeliso, hore leha ho na le ho ts'oana ho likarolo tsa bongaka le bofokoli ba boits'oaro bo amanang le taolo ea thibelo ho tšebeliso ea lithethefatsi le OCD, ts'ebetso e sebetsang libakeng tse sa thibelang e bonahala e sa lumellane, e bonts'ang phapang lits'ebetsong tsa tlhokomeliso ea mantlha e amanang le pherekano e 'ngoe le e' ngoe (53-56). Ts'ebetso e tlasa ts'ebetso ea ts'ebetso ea inhibitory bokhobeng e kanna ea amahanngoa le tlhokomelo e fokolang ea bokamoso le ho fokotseha bokhoni ba ho hanela ho etsa lintho tse amanang le lithethefatsi, athe ho OCD, ts'ebetso e kanna ea sebetsa haholo, mohlomong hobane batho ba amehile haholo ka litlamorao tsa nako e tlang. (53).

c. Ho ba kotsing ea liphatsa tsa lefutso le endophenotypes

Boithuto ba mofuta oa motho ea khethiloeng oa PG bo fana ka khokahano le li-SUD le taolo e fokolang ea taolo (23). Boithuto bo bong empa eseng lithuto tse ling bo ts'oaretse polymorphism ea Taq-A1 ea gene e kenyang receptor ea DA D2 (57-59). Mefuta e fapaneng ea mofuta oa 5HT transporter e kentse letsoho ho OCD le PG, empa mofuta oa mekhatlo e fapaneng (23), le allele e telele e fumanoeng ho kopantsoe le OCD le alamo e khuts'oane e fumanoeng e le kopanong le PG (60;61).

Ho ts'ehetsa li-OCSDs, tlhahlobo ea lihlotšoana e entsoeng ho bakuli ba OCD ba bonts'itse lihlopha tsa 3 tse arohaneng (62). Mekhahlelo e ne e bitsoa: khaello ea moputso (ho kenyeletsoa le trichotillomania, bothata ba Tourette, papali ea papali ea kelello, le lefu la hypersexual); ho hloka matla (ho kenyeletsoa ho ea mabenkeleng a qobelloang, kleptomania, mathata a ho ja, ho intša kotsi le ho phatloha ho hoholo ha lintho); le somatic (ho kenyelletsa le dysmorphic disorder le hypochondriasis). Ha ho tse amanang le mofuta o itseng oa liphatsa tsa lefutso tse ithutoang. Patlisiso ea liphatsa tsa lefutso ea bokamoso e lokela ho nka boholo ba boits'oaro (boits'oaro le ho qhekella) le endophenotypes (63). Endophenotypes e na le bokhoni ba ho lekanya matšoao a tšobotsi ao ho leng bonolo ho a lekola ho feta mafu a rarahaneng a boitšoaro kapa a ka emelang litlatsetso tse amanang haholo le tlholeho ea tlhaho ea mathata a kelello (64). Hobane lipatlisiso tsa endophenotype ho tsa mafu a kelello li sa le ncha, ho na le lintlha tse fokolang (65).

Ho bonoa ts'ebetso e sa tloaelehang ea libaka tse 'maloa tsa cortical, ho kenyelletsa le orbitofrontal cortex nakong ea ho ithuta ho feto-fetoha ho bakuli ba OCD le beng ka bona ba haufi ba sa sebetseng. Phuputsong e lekolang li-inhibitory controlprocesses, li-OCD probands le beng ka li-degree tse sa sebetseng li bonts'itse ts'oaetso (extradimensional set change) le motor impulsivity (linako tsa karabelo ea ho emisa-lets'oaetso). Lits'oaetso tsena li ka emela endophenotypesfor OCD le maemo a amanang (65;66).

Ka motor inhibition paradigm (mosebetsi oa ho emisa - SST), bakuli ba OCD ka bobeli le beng ka bona ba sa sebetseng ba ile ba bonts'a taolo e sa sebetseng ea makoloi, e tšoaelitsoeng ke latency e telele ea nako ea ho emisa lets'oao la ho emisa (SSRT), le latency e telele e ne e amahanngoa ka bobeli ba tsona bo fokotsehileng ka bophahamo ba orbitofrontal cortex le ka ho le letona le ka tlase bokong bo ka pele (libaka tse tloahelehileng tse amanang le ts'ebetso ea OCD le SST, ka ho latellana) le ho eketsa molumo oa taba ea bohlooho libakeng tsa striatum, cingulate le parietal cortex (67). Liphetho tsena li pheha khang bakeng sa tšebeliso ea pele ea sebopeho sa MRI endophenotype ea lelapa, mme mohlomong le liphatsa tsa lefutso, kotsi bakeng sa ho qhekelloa ho amanang le OCD. Datha e fana ka maikutlo a hore mofuta o joalo oa endophenot o ka sebetsa le ho PG le SUDs (24).

Methati e tlatselletsang ea ho qobelloa

a. Mehato ea kelello

Batho ba nang le OCD ba ipabola maemong a thibelo ea likotsi (68;68), athe ba nang le PG ba lekanya haufi-ufi ba nang le li-SUDs, ba ipabola maemong a ho susumetsa le ho batla lintho tse ncha (20;50;69). Leha ho le joalo, batho ba bang ba nang le OCD ba bonts'a boemo bo phahameng ba ho lemoha (70), mme batho ka bomong ba nang le PG kapa OCD ba bonts'itse maemo a phahameng a ho qoba ho potlaka le ho qoba likotsi, ho fana ka maikutlo a kamano e rarahaneng lipakeng tsa ho susumetsoa le ho qobelloa (23;71). Ka har'a li-OCSD, Hollander le Wong (72) e hlahisitse kopane ea ho hlophisa (sebopeho se kopaneng-se qobelloang) moo mathata a kelello a robetseng setšoantšong le OCD nakong ea khatello le bohlasoa ba botho bo fetelletseng. Leha ho le joalo, ho ba teng ha tšusumetso le ho ts'oaroa ka tšohanyetso maemong a mangata a lemalloang ho phephetsa khang ena. Phuputso ea PG le OCD (71) e khothalelitse hore ho senoloe sekhahla sa "Impulsive-Compulsive spectrum" maemong a mabeli a orthogonal, se hlahisang libaka tse tharo tsa psychopathological: haholo ts'usumetso, ho qobelloa pele (OCD), le khatello e sa qobelloang (PG).

Ho etsa liqeto ho bohlokoa ho PG, OCD, le SUDs (23). Phapang e ts'oanang le ea ho nka liqeto e bonts'a botebo ba ho khetha likhetho tse mpe nakong ea ts'ebetso ea papali ea papali ea chelete e fumanoe lipakeng tsa lithuto tsa taolo le tse nang le PG (73), OCD (74), le li-SUD (75). Leha ho le joalo, lithuto tse ling li fumane hore ho nka liqeto ho tiile ho OCD le ha e sitisoa ke mesebetsi e meng (76;77). Ho haella ha ho kopanyetsano liphumisong tsena ho ka bonts'a botsitso ba OCD, mme lipatlisiso tse ling hape lia hlokahala ho etsa lipatlisiso mabapi le ho qobelloa le ho etsa liqeto.

b. Mathata a hlahang

Mehlala ea Clinical le ea sechaba e bonts'a hore PG e sebetsa hammoho ka mathata a mangata a I le a II, ka likamano tse matla le SUDs (78-81). Ka bomalimabe, liteko tsa tlhahlobo ea OCD ha lia ka tsa fumaneha kamehla. Phuputsong ea St. Louis Epidemiologic Catchment Area (ECA), athe litekanyetso tse phahameng tsa menahano (li-ORs) li ile tsa bonoa lipakeng tsa bothata / papali ea methapo ea methapo le li-SUDs, OR e senoloang ea 0.6 e ile ea bonoa lipakeng tsa bothata / papali ea li-pathological le OCD (82).

Leha PG le OCD ba kanna ba se na khokahano e matla, ba arolelana li-comorbidities. Tlalehong ea Naha ea Sechaba ea Comorbidity Survey, tlhahlobo ea ba arabileng ea 2073 e ile ea hlahlojoa bakeng sa OCD (83). Batho ba fetang kotara e le 'ngoe ba arabetseng ba tlaleha ho hloloa kapa ho qobelloa nako eohle ea bophelo, empa ke palo e nyane feela ea ba arabelitsoeng e fihletseng litekanyetso tsa DSM-IV tsa bophelo bohle (2.3%) kapa 12-khoeli (1.2%) OCD. OCD e ne e amahanngoa le comorbidity e kholo, le litloaelano tse matla le mathata a ho kenella hare (ho tšoenyeha le ho sithabela) le menyako e phahameng bakeng sa li-ICD le li-SUDs. Ka kopanelo, liphumano tsena li bonts'a tlhokeho ea mehato ea OCD, PG, le litlatsetso tse ling tsa boitšoaro le boits'oaro lithutong tsa baahi le lipatlisiso tse ling tsa likamano tsa bona.

Karabelo ea kalafo

a. Lithethefatsi

Le ha ho se na lithethefatsi tse bonts'itsoeng ka semmuso bakeng sa PG, ho fumanoe litlelase tse tharo tse ka sehloohong: bahanyetsi ba opioid, maikutlo a ho feto-fetoha ha maikutlo le serotonin reuptake inhibitors (SRIs) (84;85). Batho ba hanyetsang Opioid ba joalo ka naltrexone ba fokotsa khafetsa ho nooeng le monyetla oa ho khutlela ho joala haholo (86;87). Bohanyetsi ba opioid le bona bo bonahala bo sebetsa hantle kalafong ea PG (1;88-90). Ha karabelo kalafo ea mohanyetsi oa opioid e bonahala e matla haholo bathong ba nang le nalane ea lelapa ea joala (91) Ho khothaletsoa tlhahiso ea endophenotype e amanang le bokhoba bo amanang le kalafo.

Ho ts'oana ho amanang le kalafo lipakeng tsa PG le SUDs ho ts'oana le liphetho tsa OCD. Naltrexone ha e susumetse ho teba ha OCD (92) hape e ka mpefatsa matšoao a (93;94). Mekhoa e metle ea methapo e kang lithium e ka ba molemo ho phekoleng PG (95-97) empa eseng OCD (98). Lithethefatsi tsa antipsychotic tse sebelisang DA D2-receptors (haloperidol, risperidone le olanzapine) li bonts'itse ts'ebetso e le baemeli ba matlafatsang ho OCD (99), empa li bontšitse liphumano tse mpe litekong tse laoloang ke placebo ho PG (100-102) le ho eketsa lits'oants'o tsa ho becha ho PG (103).

Ho bontšoa li-SRI bakeng sa ho phekola OCD (99) empa ba bile le liphetho tse kopaneng bakeng sa PG le SUDs (23). Liteko tse ling tsa taolo e sa reroang li fumane fluvoxamine le paroxetine li phahame ho feta placebo kalafo ea PG (104;105), mme ba bang ha ba (106;107). Litlamorao tse fapaneng tsa pharmacotherapy ho PG li fana ka maikutlo a tobileng ho mathata a hlahang a amanang le ona, joalo ka matšoenyeho (108), ha u phekola PG (79;109), 'me ho fokotseha ka nako e tšoanang ho PG ka bobeli le libaka tse hlahang li se li bonoa (96;108).

Phuputso e se nang mahlo a mabeli, e laoloang ke sebaka, e hanyetsanang le boithuto ba atypical (modafinil) ho PG e khothalelitse lihlopha tse peli tse nyane (103). Lintho tse nang le tšusumetso e phahameng li bontšitse ho fokotseha hoa tšusumetso ea ho becha, ho etsa liqeto tse kotsi, ho se ts'oaroe, le karabelo litekong tse amanang le papali ea chelete. Ba nang le khatello e tlase ba bontšitse ho eketseha ha maemo mehatong ena kaofela, ho fana ka maikutlo a phello ea modafinil e khethollang lipakeng tsa batho ba phahameng le ba tlase ba nang le PG. Seo ba se fumaneng se fana ka maikutlo a heterogeneity ho PG, e ka hlalosang sephetho se bonahalang ekare sea lumellana. Lintlha tse ling li fana ka maikutlo a hore ho potlaka ho ka emela sepheo sa bohlokoa sa kalafo ho PG (110;111). Lintlha tse hlahang hape li fana ka maikutlo mabapi le likarolo tsa kalafo ea glutamatergic kalafong ea OCD, PG, le SUDs (99;112;113), mohlomong ka ho shebella mehato e amanang le ho qobella (mohlala, ho se khonehe ha kelello)114), leha sephetho se lokela ho hlalosoa ka mokhoa o hlokolosi.

b. Ho kenella ka mekhoa ea boits'oaro

Mekgwa ya kalafo ya boitshwaro e sebetsang hantle kalafong ya SUDs e ka ba molemo ho PG le OCD (115;116). Mekhoa ea boikoetliso e mabapi le boits'oaro le tšusumetso, e kenyelletsoang ho khothaletsa lipuisano (MI) le Cognitive Behahlangu Therapy (CBT) li atlehile ho phekola li-SUDs le PG (85;117-120). Ho ba teng ho Gambler Anonymous (GA), e hlahisitsoeng kamora Alcoholics Anonymous (AA), ho amahantsoe le sephetho se betere bakeng sa batho ba nkang karolo ho tsa bongaka kalafi (121). OCD e tloaetse ho alafshoa ka mekhoa ea thibelo ea ho itlhahisa / ho thibela karabo (122;123), le mekhoa e tšoanang ea ho nahana ka takatso e tšoanang e na le ts'ehetso ho PG (124-127).

Kakaretso le Liphello

Phapang e kholo e teng lipakeng tsa PG le SUDs ka ho qobelloa ho emela mofuta oa endophenot oa bohlokoa. Leha OCD le bokhoba ba eona bo ka arolelana lintho tse tšoanang, li bonahala li fapane, li na le litekanyetso tse tlase ho feta tse lebelletsoeng tsa comorbidity ebile li fapana ka karabelo karabong ea kalafo (128). Leha ho le joalo, joalo ka ho ts'oaroa, ho qobelloa joalo ka kaho ea endophenotypic ho bohlokoa ho hlahloba lithutong tse tlang tsa li-ICD, li-SUD le OCD (42;129;130).

Mabapi le bokhoba ba boitšoaro bo bobe, PG e kanna ea ba moferefere feela o nang le data e lekaneng e teng ho tsoela pele ka sehlopha e le lekhoba la tahi (1). Ho lemalla boitšoaro bo botle ho hlahisa sepheo sa bohlokoa sa lipatlisiso tsa nako e tlang. Litla-morao tsa boitšoaro li ka ts'oana kapa li fapana le tse ling maemong a phenotypical le neurobiological ka data e teng e fanang ka maikutlo ka bobeli (131). Ho na le monyetla oa hore joalo ka OCD le mafu a mang a kelello, temallo e 'ngoe le e' ngoe ea boits'oaro e tla emela ho hloka taolo ea mantlha (132;133). H heterogeneity e joalo e lokela ho ananeloa ha ho ntse ho etsoa lipatlisiso tsa mekhahlelo e nepahetseng ea mafu le nts'etsopele ea maano a atlehang a thibelo le kalafo. Tsoelo-pele ea neurobiological e ka thusa ho utloisisa heterogeneities le ho tataisa nts'etsopele ea kalafo. Mekhoa ea kelello le ea boits'oaro e nahanang ka lihlopha tse ikhethang tsa matšoao le ho lemoha ts'oaetso ea matšoao a tšusumetso ea tšusumetso e ka lebisang ts'ebetsong e ntlafalitsoeng. Mefuta ea morao-rao ea ho susumetsa e fana ka maikutlo a hore moaho ona ha se sebopeho se fapaneng (134;135). Ho qobelloa ho kanna ha ba ho sebopeho se fapaneng, ho na le likarolo tse bonts'ang ts'ebetso e susumetsoang, e pheta-phetoang ea boits'oaro. Ho qobelloa, joalo ka ho qobelloa, ho ka emela mofuta oa bohlokoa oa li-endophenotype bakeng sa li-ICD, li-SUD le OCD (42; 129; 130.) Kaha endophenotype e emela ho hlaha lipakeng tsa mathata a rarahaneng le genotypes, li ka latela haholoanyane litekanyetso tsa tlhaho mme tsa ntlafatsoa litebello tsa thibelo le kalafo. ho kenella.

lumela hore baa fokola

Pampiri ena e qapiloe ka thuso ea thuso ea ho etela e tšehelitsoeng ke Setsi sa Lipapali sa Alberta mme karolo e ts'ehelitsoe ke lithuso tsa NIH R01 DA019039, R01 DA020908, RL1 AA017539, RC1 DA028279, le P20 DA027844, VA VISXEC le National Center ea National. bakeng sa Papali e nang le Boikarabello le Setsi sa eona sa Patlisiso mabapi le Mathata a Papali ea Chelete.

Mongolo o botlaaseng ba leqephe

Polelo ea Khopolo: Ho kenyelletsa ho ameha ha khatello litlamong tsa taolo ea tšusumetso (haholo-holo papali ea papali ea kelello), pherekano e kenelletseng le litheko tsa lithethefatsi li hlahlojoa. Ha ts'ebetso ea endophenotypic ea impulsivity e ntse e hlahlojoa le ho hlalosoa mabapi le mathata ana, ho qobelloa ha ho ithutoe hantle. Litlamorao tsa neurobiological le tsa bongaka li tšohloa.

 

Phatlalatso ea Thahasello:

Dr. Nady el-Guebaly ha a na likhohlano tsa chelete ho tsetela mabapi le litaba tse ngotsoeng ka letsoho.

Tanya Mudry ha a na likhohlano tsa lichelete tsa phaello ea ho tlaleha mabapi le litaba tsa buka ena e ngotsoeng ka letsoho.

Dr. Zohar o amohetse chelete ea ho etsa lipatlisiso le litefiso tsa ho bua ho tsoa Lundbeck hammoho le chelete ea lipatlisiso le litefiso tsa tlhahlobo ho tsoa ho Servier.

Dr. Tavares o fumane tšehetso ea lipatlisiso ho tsoa ho Cristalia, Roche, le Sandoz karolong ea hae e le Mopresidente oa Mokhatlo oa Naha oa Brazil mabapi le Kameho ea Pherekano le Mathata a Bangata a Taolo.

Ngaka Potenza o fumane tšehetso ea lipatlisiso ho tsoa ho Mohegan Sun Casino, Setsi sa Naha sa Ts'ebetso ea Boikarabello le Setsi sa Tsamaiso ea Lipatlisiso mabapi le Botsoa (mekhatlo e tšehelitsoeng ka chelete ea papali ea chelete); e buisane le ho eletsa Boehringer Ingelheim; e buisane le lithahasello tsa lichelete ho Somaxon; le Litsi tsa Laboraro, Ortho-McNeil, Oy-Control / Biotie, Glaxo-SmithKline le Psyadon meriana.

Lenane la Litlhahiso

1. Grant JE, Potenza MN, Weinstein A, Gorelick DA. Kenyelletso ea bokhoba ba boitšoaro. Koranta ea Amerika ea Tšebeliso e Mpe ea Lithethefatsi le Joala. 2010; 35 (5): 233-41. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
2. Wareham JD, Potenza MN. Bothata ba tšebeliso ea lithethefatsi le mathata a tšebeliso ea lithethefatsi. Koranta ea Amerika ea Tšebeliso e Mpe ea Lithethefatsi le Joala. 2000; 36 (5): 242-7. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
3. el-Guebaly N, Mudry T. Ts'ebeliso e mpe ea inthanete le leeto la tlhahlobo ea mafu. Psychiki ea Lefatše. 2010; 9 (2): 93-4. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
4. Holden C. Boitšoaro ba Boitšoaro ba Boitšoaro bo Hloekisitsoeng ka Proposed DSM-V. Mahlale. 2010 Feb 19; 327 (5968): 935. [E fetotsoe]
5. Mokhatlo oa American Psychiatric Association. DSM-5: Bokamoso ba tlhahlobo ea mafu a kelello. Webosaete ea nts'etsopele ea DSM-5. 2010 Nov 26; E fumaneha ho: URL: http://www.dsm5.org/Pages/Default.aspx.
6. Hollander E, Benzaquen SD. Bofokoli bo bonojo bo bonoang ka matla. Tlhahlobo ea machabeng ea Psychiatry. 1997; 9: 99-110.
7. Lejoyeux M, Weinstein A. Ho Reka ka Tlatsetso. Koranta ea Amerika ea Tšebeliso e Mpe ea Lithethefatsi le Joala. 2010; 36 (5): 248-53. [E fetotsoe]
8. Mokhatlo oa American Psychiatric Association. Tlhahlobo ea maikutlo le pherekano ea mafu a kelello. Arlington, VA: Mokhatlo oa Amerika oa Psychiatric; 2000. IV-TR ed.
9. Koob GF, Volkow ND. Neurocircuitry ea ho lemalla. Neuropharmacology. 2010; 35: 217-38. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
10. O'Brien CP, Volkow N, Li TK. Ho thoe'ng ka lentsoe? Ho lemalla tlhekefetso ho ipapisa le DSM-V. Ke J Psychiatry. 2006; 163: 764-765. [E fetotsoe]
11. Holden C. Litaba tsa ho ba le boitšoaro bo bobe: Na li teng? Mahlale. 2001; 294: 980-982. [E fetotsoe]
12. Holden C. Psychology. Qeto ea ho beha litheko tsa boits'oaro ho DSM-V e reriloeng. Mahlale. 2010; 327: 935. [E fetotsoe]
13. Hollander E, Cohen LJ. Ho susumetsa le ho qobelloa. Washington, DC: Koranta ea Amerika ea Psychiki; 1996.
14. Chamberlain SR, Fineberg NA, Blackwell AD, Robbins TW, Sahakian BJ. Inhibition ea likoloi le ho fetoha habonolo hoa kelello ho ramatiki e bonang lintho habonolo le lefu le tšoaetsang "trichotillomania". Koranta ea Amerika ea Psychiatry. 2006; 163: 1282-4. [E fetotsoe]
15. Mokhatlo oa Lefatše oa Bophelo. Classified ea Machaba ea Maloetse (10th Revision) webosaete ea Mokhatlo oa Lefatše oa Bophelo. 2010 Nov 26; E fumaneha ho: URL: http://www.who.int/classifications/icd/en/
16. Rasmussen SA, Eisen JL. Likarolo tsa Epidemiological le tsa bongaka tsa ho senyeha habonolo. Ka: Jenike MA, Baer LB, Minichielo, bahlophisi. Mathata a Tebileng: Tlhahiso le Taolo. 2. Chicago, IL: Buka ea Bongaka ea Buka ea Selemo; 1990. maq. 39-60.
17. Koob GF. Sistimi ea khatello ea kelello ho amygdala le ho lemalla. Patlisiso ea Brain. 2009; 1293: 61-75. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
18. Khale B, Robbins TW. Litsamaiso tsa Neural tsa matlafatso ea ts'ebeliso ea lithethefatsi: Ho tloha liketsong ho ea ho tloaelo. Neuroscience ea Tlhaho. 2005; 8: 1481-9. [E fetotsoe]
19. Zohar J, Fostick L, Juven-Wetzler E. Ho hloka taolo ho potelletseng. Ka: Belder M, Andreasen N, Lopez-Ibor J, Geddes J, bahlophisi. Buka e Ncha ea Oxford ea Psychiatry. 2. New York: Oxford University Press; 2009. maq. 765-73.
20. Brewer JA, Potenza MN. Neurobiology le genetics ea mathata a laoloang ke tšusumetso: Kamano le bokhoba ba lithethefatsi. Biochemical Pharmacology. 2008; 75: 63-75. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
21. Koob GF, Le Moal M. Ts'ebeliso e mpe ea lithethefatsi: Hysonic homeostatic dysregulation. Mahlale. 1997; 278: 52-8. [E fetotsoe]
22. Koob GF, Le Moal M. Bokhoba ba lithethefatsi, khatello ea moputso le allostasis. Neuropsychopharmacology. 2001; 24: 97-129. [E fetotsoe]
23. Potenza MN, Koran LM, Pallanti S. Kamano lipakeng tsa mathata a taolo ea tšusumetso le bofokoli bo potelletseng: kutlwisiso ea hajoale le lits'ebetso tsa lipatlisiso tsa nako e tlang. Patlisiso ea Psychiki. 2009; 170 (1): 22-31. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
24. de Castro V, Fong T, Rosenthal RJ, Tavares H. Papiso ea litakatso le maikutlo a maikutlo lipakeng tsa papali ea papali ea chelete le lino tse tahang. Mekhoa e Mebetsang ea Ho Sebeka. 2007; 32: 1555-64. [E fetotsoe]
25. Zohar J, Hollander E, Stein DJ, Westenberg HG. Sehlopha sa Consensus sa Cape Town. Polelo ea Consensus CNS Spectrums: Koranta ea Machabeng ea Neuropsychiatric Medicine. 2007; 12 (2 Suppl 3): 59-63. [E fetotsoe]
26. Blanco C, Moreyra P, Nunes EV, Saiz-Ruiz J, Ibanez A. Ho becha ka tsela ea tlhaho: Ho lemalla kapa ho qobella? Lisemina ho Clinical Neuropsychiatry. 2001; 6 (3): 167-76. [E fetotsoe]
27. Grant JE, Brewer JA, Potenza MN. The neurobiology ea lithethefatsi le litloaelo tsa boits'oaro. Libaka tsa CNS. 2006; 11 (12): 924-30. [E fetotsoe]
28. Robinson TE, Berridge KC. Motheo oa neural oa takatso ea lithethefatsi: Khopolo ea tšusumetso ea takatso ea ho lemalla. Tlhahlobo ea Patlisiso ea Brain. 1993; 18 (3): 247-91. [E fetotsoe]
29. Fineberg NA, Potenza MN, Chamberlain SR, Berlin HA, Menzies L, Bechara A, et al. Ho batla boits'oaro bo qobellang ebile bo sa susumetse, ho tloha mehlaleng ea liphoofolo ho ea ho endophenotypes: Tlhahlobo e phetoang. Neuropsychopharmacology. 2010; 35 (3): 591-604. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
30. Chambers RA, Taylor JR, Potenza MN. Litla-morao tsa nts'etsopele ea kholo ea bongoana: Nako e mahlonoko ea ho lemalla tlhekefetso. Psychology ea Amerika. 2003; 160: 1041-1052. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
31. Potenza MN, Hollander E. Lipapali tsa ho becha le mathata a ho laola litšusumetso. Ka: Davis KL, Charney D, Coyle JT, Nemeroff C, bahlophisi. Neuropsychopharmacology: Moloko oa 5th oa tsoelo-pele. Baltimore, MD: Lippincott Williams le Wilkins; 2002. maq. 1725-41.
32. Pauls DL, Mundo E, Kennedy JL. Pathophysiology le genetics ea obsessive-activive disorder. Ka: Davis K, Charney D, Coyle JT, Nemeroff C, bahlophisi. Neuropsychopharmacology: Moloko oa 5th oa tsoelo-pele. Baltimore, MD: Lippincott Williams le Wilkins; 2002. maq. 1609-19.
33. Gross-Isseroff R, Cohen R, Sasson Y, Voet H, Zohar J. Serotonergic disgment tsa matšoao a ho qobella ho ithuta: thuto ea phephetso e nang le m-chlorophenylpiperazine le sumatriptan. Neuropsychobiology. 2004; 50 (3): 200-5. [E fetotsoe]
34. Denys D, de Geus F, van Megan HJ, Westenberg HG. Teko e sa lahloeng habeli, e sa reroang, e laoloang ke placebo ea keketseho ea quetiapine ho bakuli ba nang le ts'oaetso e fetelletseng ea khatello ea kelello e thibelang serotonin reuptake inhibitors. Tlaleho ea Psychiki ea kelello. 2004; 65: 1040-8. [E fetotsoe]
35. Potenza MN. Na mathata a lemalloang a lokela ho kenyelletsa maemo a amanang le lintho tse sa amaneng le lithethefatsi? Ho lemalla. 2006; 101 (Suppl): 142-51. [E fetotsoe]
36. Williams WA, Potenza MN. The neurobiology ea tšusumetso ea taolo ea ts'usumetso. Revista Brasileira de Psiquiatria. 2008; 30 (Suppl 1): S24-S30. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
37. Volkow ND, Fowler JS. Bokhoba, bokuli ba ho qobella le ho khanna: Ho kenella ka cortex ea orbitofrontal. Cerebral Cortex. 2000; 10 (3): 318-25. [E fetotsoe]
38. van den Heuvel OA, der Werf YD, Verhoef KM, de Wit S, Berendse HW, Wolters ECh, et al. Boitšoaro bo bobe ba pelehi bo ka tlasa boits'oaro bo botle bo boneng bo susumetsang. Tlaleho ea Saense ea Neurological. 2010; 289 (1-2): 55-9. [E fetotsoe]
39. Leeman RF, Potenza NM. Mathata a taolo ea tšusumetso ho lefu la Parkinson: litšobotsi tsa kliniki le litlamorao. Neuropsychiatry. 2011; 1 (2): 133-147. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
40. Khale BT, Robbins TW. Litsamaiso tsa Neural tsa matlafatso ea ts'ebeliso ea lithethefatsi: Ho tloha liketsong ho ea ho tloaelo. Neuroscience ea Tlhaho. 2005; 8: 1481-9. [E fetotsoe]
41. Brewer JA, Potenza MN. Neurobiology le genetics ea mathata a laoloang ke tšusumetso: likamano le bokhoba ba lithethefatsi. Biochemical Pharmacology. 2008; 75: 63-75. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
42. Dalley JW, Everitt BJ, Robbins TW. Ho susumetsoa ke matla, ho qobella, le taolo e holimolimo e tlase. Neuron. 2011; 69: 680-694. [E fetotsoe]
43. Potenza MN. The neurobiology ea ts'ebetso ea papali ea ho becha le ho lemalla lithethefatsi: Tlhatlhobo le liphetho tse ncha. Phetohelo ea Philosophical: Saense ea Biology. 2008; 363 (1507): 3181-9. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
44. Reuter J, Raedler T, Rose M, Hand I, Glascher J, Buchel C. Tsela ea ho becha e kopantsoe le ts'ebetso e fokotsitsoeng ea sisteme ea moputso oa mesolimbic. Neuroscience ea Tlhaho. 2005; 8 (2): 147-8. [E fetotsoe]
45. Ngola J, Kahnt T, Schlagenhauf F, Beck A, Cohen MX, Knutson B, et al. Sistimi e fapaneng ea neural e lokisa boits'oaro ba makoloi ho arabela moputsong le kotlong. Neuroimage. 2007; 36 (4): 1253-62. [E fetotsoe]
46. Steeves TD, Miyasaki J, Zurowski M, Lang AE, Pellecchia G, VanEimeren T, et al. Ho eketsa tlhahiso ea dopamine e tsoang ho bakuli ba Parkinsonia ka ho becha ha methapo: Phuputso ea [11C] ea raclopride PET. Boko. 2009; 132: 1376-85. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
47. Bradberry CW. Tlhokomeliso ea cocoaine le phetisetso ea dopamine ea litlamorao ho litoeba, litšoene le batho: Libaka tsa tumellano, ho se lumellane le litlatsetso tsa ho lemalla. Psychopharmacology. 2007; 191: 705-17. [E fetotsoe]
48. Evans AH, Pavese N, Lawrence AD, Tai YF, Appel S, Doder M, et al. Ts'ebeliso e thata ea lithethefatsi e amanang le phetiso ea sensral ea transral ea striatal dopamine. Annals of Neurology. 2006; 59 (5): 852-8. [E fetotsoe]
49. Mataix-Cols D, van den Heuvel OA. Litlhaloso tsa neural tse tloaelehileng le tse ikhethileng tsa ho hloka taolo-le mamello le mathata a amanang le ona. Litliliniki tsa kelello tsa Amerika Leboea. 2006; 29: 391-410. [E fetotsoe]
50. Potenza MN, Leung HC, Blumberg HP, Peterson BS, Fulbright RK, Lacadie CM, et al. FMRI stroop task Study of ventromedial prefrontal cortical function ho ba ts'oaroang ke lefu la sethoathoa. Koranta ea Amerika ea Psychiatry. 2003; 160 (11): 1990-4. [E fetotsoe]
51. Rosenthal RJ, Lesieur HR. Matšoao a ho itlosa bolutu le ho becha ha methapo ea bophelo. Koranta ea Amerika mabapi le Likhoka. 1992; 1 (2): 150-4.
52. Lightsey OR, Hulsey CD. Ho susumetsa, ho sebetsana le maemo, khatello ea maikutlo le papali ea chelete har'a liithuti tsa univesithi. Tlaleho ea Psychology ea Tlhabollo. 2002; 49 (2): 202-11.
53. Lubman DI, Yucel M, Pantelis C. Tlatsetso, boemo ba boitšoaro bo qobelloang? Bopaki ba neuroimaging le neuropsychological ba dysregulation ea inhibitory. Ho lemalla. 2004; 99 (12): 1491-502. [E fetotsoe]
54. Nordahl TE, Benkelfat C, Semple WE, Gross M, King AC, Cohen RM. Tekanyetso ea "metabolism" ea "cerebral" e na le "metabolism" e ka sithabetsang. Neuropsychopharmacology. 1989; 2: 23-8. [E fetotsoe]
55. Volkow ND, Wang GJ, JE ka kakaretso, Hitzemann R, Fowler JS, Pappas NR, et al. Karabelo ea boko ea tikoloho ho lorazepam ho lino tse tahang nakong ea joala joala pele ho nako. Phuputso e entsoeng ka tahi le bongaka. 1997; 21: 1278-84. [E fetotsoe]
56. Maruff P, Purcell R, Pantelis C. Ho hloka taolo ho feta tekano. Ka: Harrison JE, Owen AM, bahlophisi. Khaello ea kelello likelellong tsa boko. London: Martin Dunitz; 2002. maq. 249-72.
57. Metsotso DE. Liphatsa tsa lefutso tsa ho becha tsa methapo. Libaka tsa CNS. 1998; 3 (6): 20-37.
58. Rodriguez-Jimenez R, Avila C, Ponce G, Ibanez MI, Rubio G, Jimenez-Arriero MA, et al. Pholororism ea Taq1A e amanang le mofuta oa DRD2 e amana le tlhokomelo e tlase le taolo e fokolang ea thibelo ho bakuli ba joala. Psychiki ea Europe. 2006; 21: 66-9. [E fetotsoe]
59. Lobo DS, Souza RP, Tong RP, Casey DM, Hodgins DC, Smith GJ, et al. Mokhatlo oa liphetoho tse sebetsang ho dopamine D2- joalo ka li-receptors tse nang le kotsi ea boits'oaro ba papali ea chelete lithutong tse phetseng hantle tsa Caucasian. Psychology ea Biological. 2010; 85: 33-7. [E fetotsoe]
60. Ibanez A, Blanco C, de Castro IP, Fernandez-Piqueras J, Saiz-Ruiz J. Genetics ea papali ea papali ea chelete. Tlaleho ea Lithuto tsa Boloi. 2003; 19: 11-22. [E fetotsoe]
61. Hemmings SMJ, Stein DJ. Boemo ba hajoale ba lithuto li kopane le bothateng bo bonoang ka tšohanyetso. Litliliniki tsa kelello tsa Amerika Leboea. 2006; 29: 411-44. [E fetotsoe]
62. Lochner C, Hemmings SMJ, Kinnear CJD, Niehaus J, Nel DG, Corfield VA, et al. Tlhahlobo ea tlholeho ea bothateng bo bonoang ba ho lemalla lintho tse itseng ho bakuli ba nang le bothata ba ho bona lintho ka tsela e potelletseng: likliniki le liphatsa tsa lefutso. Tlhatlhobo e akaretsang. 2005; 46: 14-9. [E fetotsoe]
63. Baca-Garcia E, Salgado BR, Segal HD, Lorenzo CV, Acosta MN, Romero MA, le al. Phuputso ea liphatsa tsa lefutso ea ho tsoala pele lipakeng tsa ho qobella le ho hloka maikutlo ho basali: serotamin transporter promoter polymorphism. Tsoelo-pele ho Neuro-psychopharmacology & Biological Psychiatry. 2005; 29 (5): 713-7. [E fetotsoe]
64. Gottesman II, Gould TD. Mohopolo oa endophenotype ho ts'ebeliso ea mafu a kelello: etymology le sepheo sa morero. Koranta ea Amerika ea Psychiatry. 2003; 160: 636-45. [E fetotsoe]
65. Chamberlain SR, Menzies L, Hampshire A, Suckling J, Fineberg NA, del Campo N, et al. Ho se sebetse hantle ha Orbitof Pambal ho bakuli ba nang le bothata ba ho bona lintho tse ba qobelloang le ba malapa a bona a sa sebetseng. Mahlale. 2008; 321: 421-2. [E fetotsoe]
66. Chamberlain SR, Fineberg NA, Menzies LA, Menzies LA, Blackwell AD, Bullmore ET, et al. Ho sitiseha ho tenyetseha hoa kelello le thibelo ea koloi maemong a amanang le bakuli ba maemo a pele a bakuli ba nang le bothata ba ho bona lintho tse ba qobellang. Koranta ea Amerika ea Psychiatry. 2007; 164: 335-8. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
67. Menzies L, Achard S, Chamberlain SR, Fineberg N, Chen CH, del Campo N, et al. Li-endophenotypes tse sa bonahaleng tsa ho senyeha habonolo. Boko. 2007; 130 (12): 3223-36. [E fetotsoe]
68. Anholt GE, Emmelkamp Tonakholo, Cath DC, van OP, Nelissen H, Smit JH. Na bakuli ba nang le OCD le papali ea chelete ba na le likakanyo tse tšoanang tse sa sebetseng? Boithuto ba Boitšoaro le Therapy. 2004; 42 (5): 529-37. [E fetotsoe]
69. Hollander E, Wong CM. Bofokoli ba 'mele bo bakoang ke ho hlaseloa ke' mele, ho becha ka methapo le ho qobelloa ho etsa thobalano. Tlaleho ea Psychiki ea kelello. 1995; 56 (Suppl 4): 7-12. [E fetotsoe]
69. Blaszczynski A, Steel Z, McConaghy N. Impulsivity ho papali ea papali ea methapo ea methapo: ea antisocial impulsivist. Ho lemalla. 1997; 92: 75-87. [E fetotsoe]
70. Ettelt S, Ruhrmann S, Barnow S, Buthz F, Hochrein A, Meyer K, et al. Ho phehella ho hloka taolo-ketsahalo e bonts'ang: litholoana tsa thuto ea lelapa. Acta Psychiatrica Scandinavica. 2007; 115 (1): 41-7. [E fetotsoe]
71. Tavares H, Gentil V. Pherekano ea ho becha le ho lemalla lintho tse poteletseng: Ho lebisa mahlong a litšitiso tsa khatello ea maikutlo. Revista Brasileira de Psiquiatria. 2007; 29 (2): 107-17. [E fetotsoe]
72. Hollander E, Wong CM. Mathata a bonoheng a shebellehang. J Clin Psychiatry. 1995; 56 (Suppl 4): 3-6. [E fetotsoe]
73. Cavedini P, Riboldi G, Keller R, D'Annucci A, Bellodi L. Frontal lobe dysfunction in pathological golf. Psychology. 2002; 51: 334-41. [E fetotsoe]
74. Cavedini P, Riboldi G, D'Annucci A, Belotti P, Cisima M, Bellodi L. Ho etsa qeto ea ho etsa heterogeneity ho ts'ebeliso e sa hlokeng botsitso: ts'ebetso ea Ventromedial prefrontal cortex e bolela litholoana tse fapaneng tsa kalafo. Neuropsychologia. 2002; 40: 205-11. [E fetotsoe]
75. Khoebo ea Bechara A. Risky: Ho ba le maikutlo, ho etsa liqeto le ho lemalla. Tlaleho ea Lithuto tsa Boloi. 2003; 19: 23-51. [E fetotsoe]
76. Chamberlain SR, Fineberg NA, Blackwell AD, Clark L, Robbins TW, Sahakian BJ. Papiso ea neuropsychological ea lefu le bonang kelello le "trichotillomania". Neuropsychologia. 2007; 45: 654-62. [E fetotsoe]
77. Watkins LH, Sahakian BJ, Robertson MM, Veale DM, Rogers RD, Pickard KM, et al. Ts'ebetso e kahare ho lefu la Tourette le ho hloka taolo. Phekolo ea kelello. 2005; 35: 571-82. [E fetotsoe]
78. Crockford DN, el-Guebaly N. Psorchiatric comorbidity ho tsibollo ea methapo ea methapo: Tlhahlobo e boima. Koranta ea Canada ea Psychiatry. 1998; 43: 43-50. [E fetotsoe]
79. Potenza MN. Phokotso ea taolo ea tšusumetso le mathata a hlahang: Ho nahanela maikutlo a lefu la bobeli. Sengoloa sa Diagnosis ea Dual. 2007; 3: 47-57.
80. Potenza MN, Xian H, Shah K, Scherrer JF, Eisen SA. Ho arolelanoa lipehelo tsa lefutso ho papali ea papali ea khatello ea maikutlo le khatello e kholo ea maikutlo ho banna. Li-Archives tsa General Psychiatry. 2005; 62 (9): 1015-21. [E fetotsoe]
81. Petry NM, Stinson FS, Grant BF. Co-morbidity ea DSM-IV ea ho becha ha methapo ea methapo le mafu a mang a kelello: liphetho tse tsoang ho National Epidemiologic Survey on Alcohol and maemong a amanang le ona. Tlaleho ea Psychiki ea kelello. 2005; 66: 564-74. [E fetotsoe]
82. Cunningham-Williams RM, Cottler LB, Compton WMI, Spitznagel EL. Ho nka menyetla: Mathata a ho becha le mathata a bophelo bo botle ba kelello: Liphetho tse tsoang thutong ea tikoloho ea St. Louis Epidemiologic Catchment Area. Koranta ea Amerika ea Bophelo ba Sechaba. 1998; 88 (7): 1093-6. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
83. Ruscio AM, Stein DJ, Chiu WT, Kessler RC. Pherekano ea lefu la bosoasoi bo khothalletsang batho ho ithuta le ho bala phetisetso ea National Comorbidity Survey Replication. Psychiatry. 2010; 15 (1): 53-63. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
84. Leung KS, Cottler LB. Phekolo ea ho becha ha methapo ea methapo. Maikutlo a hajoale ka Psychiatry. 2009; 22 (1): 69-74. [E fetotsoe]
85. Brewer JA, Grant JE, Potenza MN. Phekolo ea ho becha ha methapo ea methapo. Mathata a Keketseho le Phekolo ea Bona. 2008; 7 (1): 1-13.
86. O'Miking SS, Jaffe AJ, Chang G, Schottenfeld RS, Meyer RE, Rounsaville B. Naltrexone le ho sebetsana le boiqapelo ba boi bakeng sa ho itšepa joala: Phuputso e laoloang. Li-Archives tsa General Psychiatry. 1992; 49: 881-7. [E fetotsoe]
87. Volpicelli JR, Alterman AI, Hayashida M, O'Brien CP. Naltrexone kalafo ea ts'ebeliso ea joala. Li-Archives tsa General Psychiatry. 1992; 49 (11): 876-80. [E fetotsoe]
88. Grant JE, Kim SW, Hartman BK. Phuputso e sa laoloeng habeli, e laoloang ke placebo ea opiate antagonist naltrexone kalafong ea litabatabelo tsa methapo ea kutlo. Tlaleho ea Psychiki ea kelello. 2008; 69 (5): 783-9. [E fetotsoe]
89. Grant JE, Potenza MN, Hollander E, Cunningham-Williams R, Nurminen T, Smits G, et al. Lipatlisiso tse ngata tsa antio ea antio ea agio e sebelisang kalafo ea ho becha. Koranta ea Amerika ea Psychiatry. 2006; 163 (2): 303-12. [E fetotsoe]
90. Kim SW, Grant JE, Adson DE, Shin YC. Boithuto ba naltrexone bo sa boneng mahlo le boithuto ba placebo kalafong ea papali ea papali ea chelete. Psychology. 2001; 49 (11): 914-21. [E fetotsoe]
91. Grant JE, Kim SW, Hollander E, Potenza MN. Karabelo ea ho bolela esale pele ho bahanyetsi ba opiate le placebo kalafong ea papali ea ho becha. Psychopharmacology (Berl) 2008; 200: 521-527. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
92. Revital A, Leah F, Ari G, Joseph Z. Naltrexone augmentation ho OCD: Phuputso e entsoeng ka sefofane e laoloang mahlo ka bobeli. Eur Neuropsychopharmacol. 2008; 18 (6): 455-61. [E fetotsoe]
93. Insel TR, tsamaiso ea Pickar D. Naloxone bothateng bo hlokofatsang: Tlaleho ea linyeoe tse peli. Koranta ea Amerika ea Psychiatry. 1983; 140 (9): 1219-20. [E fetotsoe]
94. Keuler DJ, Altemus M, Michelson D, Greenberg B, Murphy DL. Litlamorao tsa boitšoaro ba ho kenella ka naloxone bothateng bo bonoang ka tšohanyetso. Psychology. 1996; 40 (2): 154-6. [E fetotsoe]
95. Dannon PN, Lowengrub K, Gonopolski Y, Musin E, Kotler M. Topiramate khahlanong le fluvoxamine kalafong ea ts'ebetso ea papali ea ho becha: Phuputso e sa reroang, e sa boneng mahlo. Clinical Neuropharmacology. 2005; 28 (1): 6-10. [E fetotsoe]
96. Hollander E, Pallanti S, Allen A, Sood E, Baldini RN. Na lithium e lokolloang e fokotsa ts'ebeliso ea papali ea chelete le ho tsitsa ho ts'oanang le placebo ho batho ba tsubang ba nang le bothata ba ho phatloha ho hoholo hoa tlhaho? Koranta ea Amerika ea Psychiatry. 2005; 162 (1): 137-45. [E fetotsoe]
97. Pallanti S, Quercioli L, Sood E, Hollander E. Lithium le kalafo ea valproate ea papali ea papali ea methapo: thuto e sa sebetseng e sa boneng. Tlaleho ea Psychiki ea kelello. 2002; 63 (7): 559-64. [E fetotsoe]
98. McDougle CJ, Price LH, Goodman WK, Charney DS, Heninger GR. Teko e laoloang ea lithium augmentation ho fluvoxamine-refractory obsessive-activive disorder: Ho hloka matla. Tlaleho ea Clinical Psychopharmacology. 1991; 11 (3): 175-84. [E fetotsoe]
99. Denys D. Pharmacotherapy ea bokhopo bo bonang-bo qobelloang le mathata a bonts'ang a pono. Litliliniki tsa kelello tsa Amerika Leboea. 2006; 29 (2): 553-84. [E fetotsoe]
100. Grant JE, Potenza MN. Mathata a taolo ea tšusumetso: Litšoaneleho tsa kliniki le tsamaiso ea meriana. Annals of Clinical Psychiatry. 2004; 16 (1): 27-34. [E fetotsoe]
101. Fong T, Kalechstein A, Bernhard B, Rosenthal R, Rugle L. Teko e laoloang habeli, e laoloang ka placebo ea olanzapine bakeng sa kalafo ea bapalami ba papali ea papali ea video. Pharmacology, Biochemistry le Boitšoaro. 2008; 89 (3): 298-303. [E fetotsoe]
102. McElroy SL, Nelson EB, Welge JA, Kaehler L, Keck PE., Jr Olanzapine kalafong ya ho betla papali ea methapo: teko e sa laoleheng e sa sebetseng ea placebo. Tlaleho ea Psychiki ea kelello. 2008; 69 (3): 433-40. [E fetotsoe]
103. Zack M, Poulos CX. Litlamorao tsa modafinil ea "atypical stimulant modafinil" ea ho becha ka nako e khutšoanyane ea papali ea papali ea papali ea papali ea chelete. Tlaleho ea Psychopharmacology. 2009; 23 (6): 660-71. [E fetotsoe]
104. Hollander E, DeCaria CM, Finkell JN, Begaz T, Wong CM, Cartwright C. Teko e sa sebetseng ea habeli ea blind-blind fluvoxamine / placebo crossover ea ho betla ha pelo. Psychology. 2000; 47 (9): 813-7. [E fetotsoe]
105. Kim SW, Grant JE, Adson DE, Shin YC, Zaninelli R. Boithuto bo laoloang ke mahlo bo habeli bo mabapi le ho sebetsa hantle le polokeho ea paroxetine kalafong ea ts'ebeliso ea methapo ea methapo. Tlaleho ea Psychiki ea kelello. 2002; 63 (6): 501-7. [E fetotsoe]
106. Blanco C, Petkova E, ez A, iz-Ruiz J. Patlisiso e laoloang ke sebaka sa sefofane sa fluvoxamine bakeng sa papali ea papali ea chelete. Annals of Clinical Psychiatry. 2002; 14 (1): 9-15. [E fetotsoe]
107. Grant JE, Kim SW, Potenza MN, Blanco C, Ibanez A, Stevens L, et al. Paroxetine kalafo ea ho becha ha methapo ea methapo: teko e laoloang ka bongata e ikemetseng. International Clinical Psychopharmacology. 2003; 18 (4): 243-9. [E fetotsoe]
108. Grant JE, Potenza MN. Phekolo ea Escitalopram ea ho becha ha methapo ea maoto le matšoenyeho a bang teng: Phuputso e entsoeng ka sefofane se bulehileng ka ho khaoloa ha mahlo a mabeli. International Clinical Psychopharmacology. 2006; 21 (4): 203-9. [E fetotsoe]
109. Hollander E, Kaplan A, Pallanti S. Litlhare tsa kalafo. Ka: Grant JE, Potenza MN, bahlophisi. Ho becha ka tsela ea tlhaho: Tataiso ea bongaka. Washington, DC: Koranta ea Amerika ea Psychiki; 2004. maq. 189-206.
110. Blanco C, Potenza MN, Kim SW, Ibáñez A, Zaninelli R, Saiz-Ruiz J, Grant JE. Boithuto ba sefofane ba ho ts'oenyeha le ho qobelloa ho ts'oasa papali ea methapo ea methapo. Patlisiso ea Psychiki. 2009; 167: 161-8. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
111. Potenza MN, Sofuoglu M, Carroll KM, Rounsaville BJ. Neuroscience ea mekhoa ea kalafo ea boitshwaro le ea lithethefatsi bakeng sa ho lemalla. Neuron. 2011; 69: 695-712. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
112. Grant JE, Kim SW, Odlaug BL. N-Acetyl cysteine, moemeli oa phetoho ea glutamate, kalafong ea papali ea papali ea methapo: Phuputso ea sefofane. Psychology. 2007; 62 (6): 652-75. [E fetotsoe]
113. Kalivas PW. The glutamate homeostasis hypothesis ea ho lemalla. Tlhahlobo ea Tlhaho Neuroscience. 2009; 10 (8): 561-72. [E fetotsoe]
114. Grant JE, Chamberlain SR, Odlaug BL, Potenza MN, Kim SW. Memantine e bonts'a tšepiso ea ho fokotsa botebo ba papali ea chelete le ho se tsitse ha kelello papaling ea papali ea chelete: Phuputso ea sefofane. Psychopharmacology (Berl) 2010; 212: 603-612. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
115. Miller WR, Leckman AL, Delaney HD, Tinkcom M. Ho latela ka nako e telele boikoetliso ba boitšoaro bo botle. Tlaleho ea lithuto tsa joala. 1992; 53 (3): 249-61. [E fetotsoe]
116. Kadden RM, Litt MD, Cooney NL, Busher DA. Kamano lipakeng tsa karolo ea papali ea methapo ea ho sebetsana ka katleho le bokhoni ba kalafo ea joala. Mekhoa e Mebetsang ea Ho Sebeka. 1992; 17 (5): 425-37. [E fetotsoe]
117. Sylvain C, Ladouceur R, Boisvert JM. Phekolo ea kelello le ea boitšoaro ea papali ea papali ea methapo: thuto e laoloang. Tlaleho ea Bongoli le Psychology ea Clinical. 1997; 65: 727-32. [E fetotsoe]
118. Hodgins DC, Currie SR, el-Guebaly N. Khothaletso e khothatsang le kalafo ea ho ithusa bakeng sa papali ea chelete. Tlaleho ea Psychical le Psychology ea Boeletsi. 2001; 69: 50-7. [E fetotsoe]
119. Petry NM, Ammerman Y, Bohl J, Doersch A, Gay H, Kadden R le ba bang. Phekolo ea kelello le boits'oaro bakeng sa batho ba papali ea papali ea chelete. Journal ea Boeletsi le Clinical Psychology. 2006; 74 (3): 555-67. [E fetotsoe]
120. Grant JE, Potenza MN. Mekhoa ea kalafo ea ho becha ha methapo ea methapo le mathata a mang a ho laola litšusumetso. Ka: Gorman J, Nathan P, bahlophisi. Tataiso ea kalafo e sebetsang. Oxford, UK: Oxford University Press; 2007. maq. 561-77.
121. Petry NM. Ho becha ho sa tsejoe ebile ho na le mekhoa e metle ea boits'oaro bakeng sa ba bechang. Tlaleho ea Lithuto tsa Boloi. 2005; 21: 27-33. [E fetotsoe]
122. Hohagen F, Winkelmann G, Rasche R, Hand I, Konig A, Munchau N, et al. Ho kopantsoe ha phekolo ea boitšoaro le fluvoxamine ha e bapisoa le kalafo ea boitšoaro le placebo. Liphetho tsa boithuto bo bongata. Koranta ea Brithani ea Psychiatry. 1998; (Netefatso ea 35): 71-8. [E fetotsoe]
123. Neziroglu F, Henricksen J, Yaryura-Tobias JA. Psychotherapy ea bonyatsi le tlhekefetso e bonts'ang: Lintlha tse tsoetseng pele le tsoelo-pele, 1995-2005. Litliliniki tsa kelello tsa Amerika Leboea. 2006; 29 (2): 585-604. [E fetotsoe]
124. Battersby M. Ts'ebeletso ea kalafo ea kalafo ea papali ea chelete ea Australia Boroa: Ho pepeseha e le mohlala oa kalafo. Seboka sa Setsi sa Patlisiso ea Lipapali sa Alberta; April 8-10, 2010; Banff, Alberta.
125. Oakes J, Battersby MW, Pols RG, Cromarty P. Tlhahiso ea ho pepeseha ha papali ea chelete ka Videoconferencing: Tlaleho ea nyeoe. Tlaleho ea Lithuto tsa Boloi. 2008; 24 (1): 107-18. [E fetotsoe]
126. Grant JE, Donahue CB, Odlaug BL, Kim SW, Miller MJ, Petry NM. Puisano ea tšohanyetso ea ho nahana le ho nahana ka tšusumetso bakeng sa papali ea papali ea methapo: teko e laoloang e sa reroang. Koranta ea Brithani ea Psychiatry. 2009 Sep; 195 (3): 266-7. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
127. Echeburua E, Baez C, Fernandez-Montalvo J. Ho bapisa katleho ea mekhoa e meraro ea phekolo kalafong ea kelello ea papali ea methapo ea mali: sephetho sa nako e telele. Boitšoaro bo botle le boithuto ba kelello. 1996; 24: 51-72.
128. Fineberg NA, Saxena S, Zohar J, Craig KJ. Bofokoli bo hlokisang botsitso: Litaba tse likolohileng. Libaka tsa CNS. 2007; 12 (5): 359-75. [E fetotsoe]
129. Fineberg NA, Potenza MN, Chamberlain SR, Berlin HA, Menzies L, Bechara A, Sahakian BJ, Robbins TW, Bullmore ET, Hollander E. O batla boits'oaro bo qobellang le bo sa susumetseng, ho tloha mehlaleng ea liphoofolo ho ea ho endophenotypes: Tlhahlobo e phetang. Neuropsychopharmacology. 2010; 35: 591-604. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
130. Gottesman II, Gould TD. Mohopolo oa endophenotype ho ts'ebeliso ea kelello: Etymology le sepheo sa maano. Ke J Psychiatry. 2003; 160: 636-45. [E fetotsoe]
131. Voon V, Sohr M, Lang AE, Potenza MN, Siderowf AD, Whetteckey J, Weintraub D, Wunderlich GR, Stacy M. Impulse taolo ea taolo ho lefu la parkinson: Nyeoe ea multicenter-control. Annals of Neurology. 2011; 69: 1-11. [E fetotsoe]
132. Milosevic A, Ledgerwood DM. Ho ajoa ha papali ea chelete ea ho becha: Tlhatlhobo e felletseng. Tlhahlobo ea Psychology ea Clinical. 2010; 30: 988-998. [E fetotsoe]
133. Ledgerwood DM, Petry NM. Ho bapala papali ea chelete ea bophelo bo botle ho latela ho tsitsipana, khatello ea maikutlo le matšoenyeho. Psychology ea Baetsi ba Tlatsetso. 2010; 24: 680-688. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
134. Meda SA, Stevens MC, Potenza MN, Pittman B, Gueorguieva R, Andrews MM, Thomas AD, Muska C, Hylton JL, Pearlson GD. Ho fuputsa boits'oaro ba boits'oaro le boits'oaro ba ho hlahisa litlaleho tsa tšusumetso e sebelisa tlhahlobo ea karolo ea mantlha. Behav Pharmacol. 2009; 20: 390-9. [Tlhahiso ea mahala ea PMC] [E fetotsoe]
135. Whiteside SP, Lynam DR, Miller JD, Reynolds SK. Ho netefatsoa ha sekhahla sa boitšoaro bo sa susumetseng sa UPPS: mohlala oa lintlha tse 'nè tsa ho hloka matla. Eur J Pers. 19: 559-74.